Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor

EMBO Journal

Volumn 16, Issue 10, 1997, Pages 2892-2906

  Meroni, Germana ^a   Reymond, Alexandre ^b   Alcalay, Myriam ^c   Borsani, Giuseppe ^a   Tanigami, Akira ^d   Tonlorenzi, Rossana ^a   Lo Nigro, Cristiana ^a   Messali, Silvia ^a   Zollo, Massimo ^a   Ledbetter, David H ^e   Brent, Roger ^b   Ballabio, Andrea ^a   Carrozzo, Romeo ^a,f  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e UNIVERSITY OF CHICAGO   (United States)

^f SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

bHLHZip proteins; Max interacting proteins; Myc; sin3; Transcriptional repressor

Indexed keywords

DNA; HELIX LOOP HELIX PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 17P; CONTROLLED STUDY; FETUS; FIBROBLAST; GENE ISOLATION; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION; REPRESSOR GENE; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BINDING SITES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CLONING, MOLECULAR; DIMERIZATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; LEUCINE ZIPPERS; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0030981453     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.10.2892     Document Type: Article

References (93)

1. Abrams, H.D., Rohrschneider, L.R. and Eisenman, R.N. (1982) Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell, 29, 427-439.
2. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, D.J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
3. Amati, B., Dalton, S., Brooks, M.W., Littlewood, T.D., Evan, G.I. and Land, H. (1992) Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature, 359, 423-126.
4. Amati, B., Brooks, M.W., Levy, N., Littlewood, T.D., Evan, G.I. and Land, H. (1993) Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell, 72, 233-245.
5. Andreassen, A. et al. (1993) p53 abnormalities in different subtypes of human sarcomas. Cancer Res., 53, 468-471.
6. Anthony-Cahill, S.J., Benfield, P.A., Fairman, R., Wasserman, Z.R., Brenner, S.L., Stafford, W.F., Altenbach, C., Hubbell, W.L. and DeGrado, W.F. (1992) Molecular characterization of helix-loop-helix peptides. Science, 255, 979-983.
7. Ayer, D.E. and Eisenman, R.N. (1993) A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Der., 7, 2110-2119.
8. Ayer, D.E., Kretzner, L. and Eisenman, R.N. (1993) Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 72, 211-222.
9. Ayer, D.E., Lawrence, Q.A. and Eisenman, R.N. (1995) Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor sin3. Cell, 80, 767-776.
10. Baldin, V., Lukas, J., Marcote, M.J., Pagano, M. and Draetta, G. (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev., 7, 812-821.
11. Battey, J., Moulding, C. Taub, R., Murphy, W., Stewart, T., Potter, H., Lenoir, G. and Leder, P. (1983) The human c-Myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell, 34, 779-787.
12. Beckmann, H., Su, L.K. and Kadesch, T. (1990) TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev., 4, 167-179.
13. Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L. and Weintraub, H. (1990) The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell, 61, 49-59.
14. Berberich, S.J. and Cole, M.D. (1992) Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev., 6, 166-176.
15. Berberich, S., Hyde-DeRuyscher, N., Espenshade, P. and Cole, M. (1992) Max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. Oncogene, 7, 775-779.
16. Biegel, J.A., Burk, C.D., Barr, F.G. and Emanuel, B.S. (1992) Evidence for a 17p tumor related locus distinct from p53 pediatric primitive neuroectodermal tumors. Cancer Res., 52, 3391-3395.
17. Blackwell, T.K., Huang, J., Ma, A., Kretzner, L., Alt, F.W., Eisenman, R.N. and Weintraub, H. (1993) Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol., 13, 5216-5224.
18. Blackwood, E.M. and Eisenman, R.N. (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 251, 1211-1217.
19. Blackwood, E.M., Kretzner, L. and Eisenman, R.N. (1992a) Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev., 2, 227-235.
20. Blackwood, E.M., Luscher, B. and Eisenman, R.N. (1992b) Myc and Max associate in vivo. Genes Dev., 6, 71-80.
21. Bousset, K., Oelschlager, M.H., Henriksson, M., Schreek, S., Burkardt, H., Litchfield, D.W., Lüscher-Firzlaff, J.M. and Lüscher, B. (1994) Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II. Cell. Mol. Biol. Res., 40, 501-511.
22. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. and Bishop, J.M. (1984) Amplification of N-Myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121-1124.
23. Cai, M. and Davis, R.W. (1990) Yeast centromere binding protein CBF1, of the helix-loop-helix protein family, is required for chromosome stability and methionine prototrophy. Cell, 61, 437-446.
24. Carr, C.S. and Sharp, P. (1990) A helix-loop-helix protein related to the immunoglobulin E box-binding proteins. Mol. Cell. Biol., 10, 4384-4388.
25. Carrozzo, R. and Ledbetter, D.H. (1993) Dinucleotide repeat polymorphism mapping to the critical region for lissencephaly (17p13.3). Hum. Mol. Genet., 2, 615.
26. Chen, J., Willingham, T., Margraf, L.R., Schreiber-Agus, N., DePinho, R.A. and Nisen, P.D. (1995) Effects of the Myc oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nature Med., 1, 638-643.
27. Chin, L., Schreiber-Agus, N., Pellicer, I., Chen, K., Lee, H.-W., Dudast, M., Cordon-Cardo, C. and DePinho, R.A. (1995) Contrasting roles for Myc and Mad proteins in cellular growth and differentiation. Proc. Natl Acad. Sci. USA, 92, 8488-8492.
28. Chomczynsky, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
29. Claverie, J.M. and States, D.J. (1993) Information enhancement methods for large scale sequence analysis. Comput. Chem., 17, 191-201.
30. Dang, C.V., Barrett, J., Villa-Garcia, M., Resar, L.M.S., Kato, G.J. and Fearon, E.R. (1991) Intracellular leucine-zipper interactions suggest c-Myc hetero-oligomerization. Mol. Cell. Biol., 11, 954-962.
31. Desbarats, L., Gaubatz, S. and Eilers, M. (1996) Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev., 10, 447-460.
32. Eagle, L.R., Yin, X., Brothman, A.R., Williams, B.J., Atkin, N.B. and Prochownik, E.V. (1995) Mutation of the MXI1 gene in prostate cancer. Nature Genet., 9, 249-255.
33. Eilers, M., Schirm, S. and Bishop, J.M. (1991) The Myc protein activates transcription of the alpha-prothymosin gene. EMBO J., 10, 133-141.
34. Ellenberger, T., Fass, D., Arnaud, M. and Harrison, S.C. (1994) Crystal structure of transcription factor E47: e-box recognition by a basic region helix-loop-helix dimer. Genes Dev., 8, 970-980.
35. Estojak, J., Brent, R. and Golemis, E.A. (1995) Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol., 15, 5820-5829.
36. Estruch, F. (1991) The yeast putative transcriptional repressor RGM1 is a proline-rich zinc finger protein. Nucleic Acids Res., 19, 4873-4877.
37. Ferré-D'Amaré, A.R., Prendergast, G.C., Ziff, E.B. and Burley, S.K. (1993) Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature, 363, 38-45.
38. Ferré-D'Amaré, A.R., Pognognec, P., Roeder, R.G. and Burley, S.K. (1994) Structure and function of the b/HLH/Z domain of USF. EMBO J., 13, 180-189.
39. Finley, R.L., Jr and Brent, R. (1994) Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. Proc. Natl Acad. Sci. USA, 91, 12980-12984.
40. Fisher, D.E., Parent, L.A. and Sharp, P.A. (1993) High affinity DNA-binding Myc analogs: recognition by an α-helix. Cell, 72, 467-476.
41. Galaktionov, K., Chen, X. and Beach, D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517.
42. Gaubatz, S., Meichle, A. and Eilers, M. (1994) An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc. Mol Cell Biol., 14, 3853-3862.
43. Gessler, M. Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H. and Bruns, G.A. (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774-778.
44. Graham, F.L. and Van der Eb, A.J. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 2, 456-464.
45. Gregor, P.D., Sawadogo, M. and Roeder, R.G. (1990) The adenovirus major late transcription factor USF is a memeber of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev., 4, 1730-1740.
46. Guarente, L. and Mason, T. (1983) Heme regulates transcription of the CYC1 gene of S.cerevisiae via an upstream activation site. Cell, 32, 1279-1286.
47. Han, K. and Manley, J.L. (1993) Transcriptional repression by the Drosophila even-skipped protein: definition of a minimal repression domain. Genes Dev., 7, 491-503.
48. Harris, P. and Ralph, P. (1985) Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukocyte Biol., 37, 407-422.
49. Hu, Y.F., Luscher, B., Admon, A., Mermod, N. and Tjian, R. (1990) Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev., 4, 1741-1752.
50. Hurlin, P.J., Ayer, D.E., Grandori, C. and Eisenman, R.N. (1994) The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harbor Symp. Quant. Biol., LIX, 109-116.
51. Hurlin, P.J., Foley, K.P., Ayer, D.E., Eisenman, R.N., Hanahan, D. and Arbeit, J.M. (1995a) Regulation of Myc and Mad during epidermal differention and HPV-associated tumorigenesis. Oncogene, 11, 2487-2501.
52. Hurlin, P.J., Queva, C., Koskinen, P.J., Steingrimsson, E., Ayer, D.E., Copeland, N.G., Jenkins, N.A. and Eisenman, R.N. (1995b) Mad3 and Mad4: novel Max-interacting transcriptionl repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J., 14, 5646-5659.
53. Kato, G.J., Barrett, J., Villa-Garcia, M. and Dang, C.V. (1990) An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol., 10, 5914-5920.
54. Kato, G.K., Lee, W.M.F., Chen, L. and Dang, C.V. (1992) Max: functional domains and interaction with c-Myc. Genes Dev., 6, 81-92.
55. Keleher, C.A., Redd, M.J., Schultz, J., Carlson, M. and Johnson, A.D. (1992) Ssn6-Tup1 is a general repressor of transcription in yeast. Cell, 68, 709-719.
56. Kozak, M. (1984) Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res., 12, 857-873.
57. Kretzner, L., Blackwood, E.L. and Eisenman, N. (1992) Myc and Max proteins posses distinct transcriptional activities. Nature, 359, 426-429.
58. Lahoz, E.G., Xu, L., Schreiber-Agus, N. and DePinho, R.A. (1994) Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc. Natl Acad. Sci. USA, 91, 5503-5507.
59. Land, H., Parada, L.F. and Weinberg, R.A. (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 304, 596-601.
60. Landschulz, W.H., Johnson, P.F. and McKnight, S.L. (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science, 240, 1759-1764.
61. Larsson, L.-G., Petterson, M., Oberg, F., Nilsson, K. and Luscher, B. (1994) Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene, 9, 1247-1252.
62. Lassar, A.B., Buskin, J.N., Lockshon, D., Davis, R.L., Apone, S., Hauschka, S.D. and Weintraub, H. (1989) MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell, 58, 823-831.
63. Ledbetter, S.A., Wallace, M.R., Collins, F.S. and Ledbetter, D.H. (1990) Human chromosome 17 NotI linking clones and their use in long-range restriction mapping of the Miller-Dieker chromosome region (MDCR) in 17p13.3. Genomics, 7, 264-269.
64. Ledbetter, S.A., Kuwano, A., Dobyns, W.B. and Ledbetter, D.H. (1992) Microdeletions of chromosome 17p13 as a cause of isolated lissencephaly. Am. J. Hum. Genet., 50, 182-189.
65. Lindblom, A., Skoog, L., Andersen, T.I., Rotstein, S., Nordenskjöld, M. and Larsson, C. (1993) Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinoma. Hum. Genet., 91, 6-12.
66. Littlewood, T.D., Amati, B., Land, H. and Evan, G.I. (1992) Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene, 7, 1783-1792.
67. Lombardi, L., Newcomb, E.W. and Dalla-Favera, R. (1987) Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell, 49, 161-170.
68. Ma, P.C.M., Rould, M.A., Weintraub, H. and Pabo, C.O. (1994) Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell, 77, 451-459.
69. Marcu, K.B., Bossone, S.A. and Patel, A.J. (1992) Myc function and regulation. Annu. Rev. Biochem., 61, 809-860.
70. McDonald, J.D., Daneshvar, L., Willert, J.R., Matsumura, K., Waldman, F. and Cogen, P.H. (1994) Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics, 23, 229-232.
71. Mermod, N., O'Neill, E.A., Kelly, T.J. and Tjian, R. (1989) The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell, 58, 741-753.
72. Mugrauer, G., Alt, F.W. and Ekblom, P. (1988) N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J. Cell Biol. 107, 1325-1335.
73. Murre, C., McCaw, P.S. and BaltimorevD. (1989) A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, myoD, and Myc proteins. Cell, 56, 777-784.
74. Nau, M.M. et al. (1985) L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature, 318, 69-73.
75. Nordeen, S.K. (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. BioTechniqites, 6, 454-457.
76. Packham, G. and Cleveland, J.L. (1995) The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr. Top. Microbiol. Immunol., 194, 283-290.
77. Persson, H. and Leder, P. (1984) Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science, 225, 718-721.
78. Phillips, N., Ziegler, M., Saha, B. and Xynos, F. (1993) Allelic loss on chromosome 17 in human ovarian cancer. Int. J. Cancer, 54, 85-91.
79. Prendergast, G.C., Lawe, D. and Ziff, E.B. (1991) Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell, 65, 395-407.
80. Reymond, A. and Brent, R. (1995) p16 proteins from melanoma-prone families are deficient in binding to Cdk4. Oncogene, 11, 1173-1178.
81. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
82. Saxena, A., Clark, W.C. Robertson, J.T., Ikejiri, B., Oldfield, E.H. and Ali, I.U. (1992) Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res., 52, 6716-6721.
83. Schreiber-Agus, N., Chin, L, Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A.I. and DePinho, R.A. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell, 80, 777-786.
84. Schwab, M., Varmus, H.E. and Bishop, J.M. (1985) Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature, 316, 160-162.
85. Spector, D.L. (1993) Macromolecular domains within the cell nucleus. Annu. Rev. Cell Biol., 9, 265-315.
86. Stack, M. et al. (1995) Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum. Mol. Genet., 4, 2047-2055.
87. Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J.M., Varmus, H. and Lee, W. (1987) Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol., 7, 1697-1709.
88. Takebe, Y., Seiki, M., Fujisawa, J.-I., Hoy, P., Yokota, K., Arai, K.-I., Yoshida, M. and Arai, N. (1988) SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the Simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol., 8, 466-472.
89. Takemoto, C. and Fisher, D.E. (1995) Structural constraints for DNA recognition by Myc and other b-HLH-Zip proteins: design of oncoprotein analogues. Gene Expression, 4, 311-317.
90. Williamson, I.P., Elder, P.A. and KnowlesvM.A. (1994) The spectrum of Tp53 mutations in bladder carcinoma. Genes Chromosomes Cancer, 9, 108-118.
91. Wootton, J.C. and Federhen, S. (1993) Statistics of local complexity in amino acid sequences and sequence databases. Comput. Chem., 17, 149-163.
92. Zervos, A.S., Gyuris, J. and Brent, R. (1993) Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72, 223-232.
93. Zervos, A.S., Faccio, L., Gatto, J.P., Kyriakis, J.M. and Brent, R. (1995) Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. Proc. Natl Acad. Sci. USA. 92, 10531-10534.